This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Aug;6(8):442-3.

doi: 10.1038/nrrheum.2010.101.

Therapy: Challenging the course of RA: time for drug-free remission?

PMID: 20676124
DOI: 10.1038/nrrheum.2010.101

Therapy: Challenging the course of RA: time for drug-free remission?

Daniel Aletaha. Nat Rev Rheumatol. 2010 Aug.

. 2010 Aug;6(8):442-3.

doi: 10.1038/nrrheum.2010.101.

Author

PMID: 20676124
DOI: 10.1038/nrrheum.2010.101

No abstract available

PubMed Disclaimer

Similar articles

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.
Tanaka Y, Takeuchi T, Mimori T, Saito K, Nawata M, Kameda H, Nojima T, Miyasaka N, Koike T; RRR study investigators. Tanaka Y, et al. Ann Rheum Dis. 2010 Jul;69(7):1286-91. doi: 10.1136/ard.2009.121491. Epub 2010 Apr 1. Ann Rheum Dis. 2010. PMID: 20360136 Free PMC article.
Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
Toki H, Momohara S, Tsukahara S, Ikari K. Toki H, et al. J Rheumatol. 2008 Sep;35(9):1896-7; author reply 1897. J Rheumatol. 2008. PMID: 18785300 No abstract available.
Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.
Kuusalo L, Puolakka K, Kautiainen H, Blåfield H, Eklund KK, Ilva K, Kaipiainen-Seppänen O, Karjalainen A, Korpela M, Valleala H, Leirisalo-Repo M, Rantalaiho V; Neo-RACo Study Group. Kuusalo L, et al. Scand J Rheumatol. 2015;44(6):449-55. doi: 10.3109/03009742.2015.1043142. Epub 2015 Aug 31. Scand J Rheumatol. 2015. PMID: 26324784 Clinical Trial.
[New drugs and treatment strategies for rheumatoid arthritis].
Fantini F. Fantini F. Recenti Prog Med. 2003 Sep;94(9):361-79. Recenti Prog Med. 2003. PMID: 12942798 Review. Italian.
[Infliximab for therapy of rheumatoid arthritis].
Amano K. Amano K. Nihon Rinsho. 2005 Jan;63 Suppl 1:517-20. Nihon Rinsho. 2005. PMID: 15799410 Review. Japanese. No abstract available.

See all similar articles

Cited by

Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, Jacobs WC, van Herwaarden N, den Broeder AA. Verhoef LM, et al. Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.

References

1. Ann Rheum Dis. 2010 Jul;69(7):1286-91 - PubMed
1. Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35 - PubMed
1. Joint Bone Spine. 2009 Jul;76(4):350-5 - PubMed
1. Ann Rheum Dis. 2010 Apr;69(4):631-7 - PubMed
1. Ann Rheum Dis. 2009 Jun;68(6):823-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information